Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1148277

registered interest
date	03/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives from the British Nuclear Medicine Society on the delivery of medical radioisotopes.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	294085
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p> </p><p>The department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>For any products that require air freight, such as some medical radioisotopes, the Department is continuing to work with all suppliers to ensure this is in place ahead of 31 October. The Department can confirm that all relevant suppliers now have plans in place or are already airfreighting into the United Kingdom.</p><p> </p><p>The Department is also undertaking joint operational testing, with key suppliers and other Government Departments (Border Delivery Group, HM Revenue and Customs, Border Force) at East Midlands airport to ensure the uninterrupted flow of goods. This testing includes medical radioisotopes.</p><p> </p><p>The Department is in active communication with the British Nuclear Medicine Society as well as with the Royal College of Radiologists and the UK Radiopharmacy Group.</p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 294083 question first answered 08/10/2019 12:53:16 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1145761

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is rationing the supply of medical isotopes in advance of the UK potentially leaving the EU without a deal; and what steps he is taking to ensure an adequate supply of medical isotopes in the event that the UK leaves the EU without a deal.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	291038
answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products, including medical radioisotopes, when we leave the EU on 31 October.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medical products, including medical radioisotopes, to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>As with our plans leading up to 29 March, for those medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes for use in the diagnosis and treatment of cancer, we have asked suppliers to make alternative arrangements, using airfreight, which some suppliers are already doing. We have offered support to companies to arrange this and are actively working with suppliers to ensure detailed plans are in place ahead of the 31 October.</p><p><strong> </strong></p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:52:16 answering member 4362 label Biography information for Edward Argar
tabling member	4523 label Biography information for Catherine West

1131782

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of (a) national and (b) regional supplies of radionuclide chemicals.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	263719
answer	answer is ministerial correction date of answer 17/06/2019 answer text <p>The Department is not aware of any disruption to the supply of medical radionuclide chemicals (radioisotopes) at a national level. However, the Department does not hold information about the volume of any of medical radioisotopes that are currently available at a national or regional level.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/06/2019 15:29:33 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead

1121380

registered interest
date	11/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has with NHS England on ensuring adequate supplies of Choline for cancer (a) scans and (b) diagnoses.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	244179
answer	answer is ministerial correction date of answer 23/04/2019 answer text <p>The Department has been in regular contact with NHS England regarding the availability of Choline used for PET scanning. Choline supplies are currently available and NHS England has taken a number of steps to stabilise the availability of Choline going forward to ensure adequate supply remains available for PET scanning.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 23/04/2019 14:02:40 answering member 4455 label Biography information for Seema Kennedy
tabling member	4510 label Biography information for Helen Hayes

1104860

registered interest
date	25/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of leaving the EU without an agreement on the UK’s ability to access (a) radioactive isotopes to diagnose and treat breast cancer and (b) other such medical materials.
tabling member constituency	Houghton and Sunderland South
tabling member printed	Bridget Phillipson
uin	236430
answer	answer is ministerial correction date of answer 28/03/2019 answer text <p>Leaving the European Union with a deal remains the Government’s top priority. However, as a responsible Government we must plan for every possible outcome including ‘no deal’. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>The Government has been working closely with industry to ensure the supply of medicines, including medical radioisotopes to diagnose and treat breast cancer, can continue uninterrupted in the event of a ‘no deal’ EU exit.</p><p> </p><p>For any products that require air freight, such as medical radioisotopes, we are continuing to work with all suppliers to ensure this occurs. The Department can confirm that companies supplying the vast majority of medical radioisotopes medicines by volume have air freight routes that are currently operational.</p><p> </p><p>The Department wrote to all suppliers of medicines to the United Kingdom on 26 March to advise them of the changes to EU exit dates, and ask them to continue with preparations to protect patients in all possible outcomes.</p><p> </p><p>We are confident that, if everyone does what they need to do, the supply of medicines and medical products will be uninterrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 28/03/2019 16:27:06 answering member 1585 label Biography information for Stephen Hammond
tabling member	4046 label Biography information for Bridget Phillipson

1081917

registered interest
date	04/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effect of the UK leaving the EU without a deal on the availability of technetium and krypton generators for nuclear medicine procedures in hospitals.
tabling member constituency	East Dunbartonshire
tabling member printed	Jo Swinson
uin	228055
answer	answer is ministerial correction date of answer 07/03/2019 answer text <p>Our number one priority is for patients to continue to have access to medicines, including medical radioisotopes such as krypton and technetium, whatever the European Union exit outcome, and we have robust contingency plans in place.</p><p> </p><p>Leaving the EU with a deal remains the Government’s top priority. However, as a responsible Government we must plan for every possible outcome including ‘no deal’. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>The Department has worked with the pharmaceutical industry to ensure that planes are contracted to bring in medical radioisotopes under the appropriate specialist conditions and suppliers are working closely with the National Health Service to minimise any potential impact of changes to delivery times.</p><p> </p><p>We are confident that if everyone does what they need to do, the supply of medicines and other medical products, including medical radioisotopes, will be uninterrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 228056 question first answered 07/03/2019 12:00:45 answering member 1585 label Biography information for Stephen Hammond
tabling member	1513 label Biography information for Jo Swinson

1081918

registered interest
date	04/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Secretary of State for Transport on transporting technetium and krypton generators by air instead of road in the event that the UK leaves the EU without deal; and if he will make a statement.
tabling member constituency	East Dunbartonshire
tabling member printed	Jo Swinson
uin	228056
answer	answer is ministerial correction date of answer 07/03/2019 answer text <p>Our number one priority is for patients to continue to have access to medicines, including medical radioisotopes such as krypton and technetium, whatever the European Union exit outcome, and we have robust contingency plans in place.</p><p> </p><p>Leaving the EU with a deal remains the Government’s top priority. However, as a responsible Government we must plan for every possible outcome including ‘no deal’. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>The Department has worked with the pharmaceutical industry to ensure that planes are contracted to bring in medical radioisotopes under the appropriate specialist conditions and suppliers are working closely with the National Health Service to minimise any potential impact of changes to delivery times.</p><p> </p><p>We are confident that if everyone does what they need to do, the supply of medicines and other medical products, including medical radioisotopes, will be uninterrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 228055 question first answered 07/03/2019 12:00:45 answering member 1585 label Biography information for Stephen Hammond
tabling member	1513 label Biography information for Jo Swinson

1077136

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of radioisotope suppliers have confirmed that freight provisions are in place to avoid delays at ports preventing people accessing cancer treatments as a result of the UK leaving the EU without a deal.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	225530
answer	answer is ministerial correction date of answer 05/03/2019 answer text <p>Leaving the European Union with a deal remains the Government’s top priority - this has not changed. However, as a responsible Government, we must plan for every possible outcome including ‘no deal’. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p>We are reliant on transport and freight being re-routed but are confident that, if everyone – including suppliers, freight companies, the health and care system and international partners - does what they should do, the supply of medicines and other medical products, including medical radioisotopes, will be uninterrupted.</p><p>The Department has put in place a multi-layered approach to minimise any supply disruption:</p><p>- securing, via the Department for Transport, additional roll on roll off freight capacity (away from the short straits crossings to Dover and Folkestone) for goods to continue to come into the United Kingdom from 29 March;</p><p>- asking industry to build up stockpiles in the UK before 29 March;</p><p>- buying extra warehouse space for the additional stock to be held in;</p><p>- supporting companies in booking space on aeroplanes for products which require an immediate shipment due to short shelf-life, including medical radioisotopes, or specific storage conditions;</p><p>- making changes to, or clarifications of, certain regulatory requirements so that companies can continue to sell their products in the UK even if we have ‘no deal’; and</p><p>- strengthening the processes and resources used to deal with shortages in the event that they do occur.</p><p>There is cross-Government agreement that all medicines and medical products will be prioritised on these alternative routes to ensure that the flow of all these products may continue unimpeded. For any products that require air freight, such as medical radioisotopes, we are continuing to work with suppliers to ensure this continues as normal.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 05/03/2019 14:34:21 answering member 1585 label Biography information for Stephen Hammond
tabling member	4368 label Biography information for Neil Coyle

1064309

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received on alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the UK.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	223789
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p> </p><p>We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify ‘urgent goods’, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.</p><p> </p><p>From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department’s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 224533 question first answered 28/02/2019 11:47:48 answering member 1585 label Biography information for Stephen Hammond
tabling member	4433 label Biography information for Thangam Debbonaire

1064781

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of a shortage of radioisotopes on the number of breast cancer diagnostic and treatment procedures.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	224533
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p> </p><p>We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify ‘urgent goods’, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.</p><p> </p><p>From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department’s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 223789 question first answered 28/02/2019 11:47:49 answering member 1585 label Biography information for Stephen Hammond
tabling member	4433 label Biography information for Thangam Debbonaire